L. Pagliaro

3.5k total citations · 1 hit paper
74 papers, 2.5k citations indexed

About

L. Pagliaro is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L. Pagliaro has authored 74 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hepatology, 37 papers in Epidemiology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L. Pagliaro's work include Liver Disease Diagnosis and Treatment (31 papers), Liver Disease and Transplantation (17 papers) and Hepatitis C virus research (14 papers). L. Pagliaro is often cited by papers focused on Liver Disease Diagnosis and Treatment (31 papers), Liver Disease and Transplantation (17 papers) and Hepatitis C virus research (14 papers). L. Pagliaro collaborates with scholars based in Italy, Brazil and France. L. Pagliaro's co-authors include Rosa G Simonetti, Linda Pasta, Anna Marina Liberati, Catia Angiolini, Didier Lebrec, Thierry Poynard, Paul Calès, G. Idéo, Mario Cottone and M. Caltagirone and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

L. Pagliaro

72 papers receiving 2.4k citations

Hit Papers

Competing risks and prognostic stages of cirrhosis: a 25‐... 2014 2026 2018 2022 2014 100 200 300

Peers

L. Pagliaro
L. Pagliaro
Citations per year, relative to L. Pagliaro L. Pagliaro (= 1×) peers Rodrigo Liberal

Countries citing papers authored by L. Pagliaro

Since Specialization
Citations

This map shows the geographic impact of L. Pagliaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Pagliaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Pagliaro more than expected).

Fields of papers citing papers by L. Pagliaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Pagliaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Pagliaro. The network helps show where L. Pagliaro may publish in the future.

Co-authorship network of co-authors of L. Pagliaro

This figure shows the co-authorship network connecting the top 25 collaborators of L. Pagliaro. A scholar is included among the top collaborators of L. Pagliaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Pagliaro. L. Pagliaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fusco, Giovanna Marta, et al.. (2023). Metabolic Profiling in Tuberous Roots of Ranunculus asiaticus L. as Influenced by Vernalization Procedure. Plants. 12(18). 3255–3255. 3 indexed citations
2.
Travis, Lois B., Sophie D. Fosså, Howard D. Sesso, et al.. (2014). Chemotherapy-Induced Peripheral Neurotoxicity and Ototoxicity: New Paradigms for Translational Genomics. JNCI Journal of the National Cancer Institute. 106(5). dju044–dju044. 93 indexed citations
3.
Aparicio, Ana M., Andrea Harzstark, Emile N.J.T. van Lin, et al.. (2011). Characterization of the anaplastic prostate carcinomas: A prospective two-stage phase II trial of frontline carboplatin and docetaxel (CD) and salvage etoposide and cisplatin (EP).. Journal of Clinical Oncology. 29(15_suppl). 4666–4666. 3 indexed citations
4.
Pagliaro, L., et al.. (2009). Why are Cochrane hepato-biliary reviews undervalued by physicians as an aid for clinical decision-making?. Digestive and Liver Disease. 42(1). 1–5. 10 indexed citations
5.
Morisco, Filomena, L. Pagliaro, N. Caporaso, et al.. (2008). Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels. Digestive and Liver Disease. 40(7). 585–598. 17 indexed citations
6.
Bertazzolo, Walter, et al.. (2004). Clinical, Cytological and Molecular Evidence ofMesocestoidessp. Infection in a Dog from Italy. Journal of Veterinary Medicine Series A. 51(9-10). 435–438. 28 indexed citations
7.
Fagiuoli, S., V.G. Mirante, Maurizio Pompili, et al.. (2002). Liver transplantation: the Italian experience. Digestive and Liver Disease. 34(9). 640–648. 30 indexed citations
8.
Cottone, Mario, Giada Pietrosi, Giuseppe Martorana, et al.. (2001). Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. The American Journal of Gastroenterology. 96(3). 773–775. 217 indexed citations
9.
Madonia, Salvatore, Gennaro D’Amico, Mario Traina, et al.. (2000). Prognostic indicators of successful endoscopic sclerotherapy for prevention of rebleeding from oesophageal varices in cirrhosis: a long-term cohort study. Digestive and Liver Disease. 32(9). 782–791. 8 indexed citations
10.
Simonetti, Rosa G, Anna Marina Liberati, Catia Angiolini, & L. Pagliaro. (1997). Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials. Annals of Oncology. 8(2). 117–136. 295 indexed citations
11.
Craxı̀, Antonio, V. Di Marco, Piero Luigi Almasio, et al.. (1994). COMMUNITY-ACQUIRED CHRONIC HEPATITIS-C IN AN AREA OF HIGH SEROTYPE-1 ENDEMICITY - INTERFERON FOR 6 OR 12 MONTHS. Hepatology. 20. 2 indexed citations
12.
Battezzati, Pier Maria, Mauro Podda, R. Naccarato, et al.. (1993). Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Journal of Hepatology. 17(3). 332–338. 58 indexed citations
13.
Franchis, Roberto de, Jean‐Pierre Pascal, Ermanno Ancona, et al.. (1992). Definitions, methodology and therapeutic strategies in portal hypertension. Journal of Hepatology. 15(1-2). 256–261. 217 indexed citations
14.
Magrin, S., Antonio Craxı̀, G Fiorentino, et al.. (1991). Is autoimmune chronic active hepatitis a HCV-related disease?. Journal of Hepatology. 13(1). 56–60. 52 indexed citations
15.
Israel, Yedy, H Orrego, W. Schmidt, et al.. (1991). Trauma in Cirrhosis: An Indicator of the Pattern of Alcohol Abuse in Different Societies. Alcoholism Clinical and Experimental Research. 15(3). 433–437. 5 indexed citations
16.
Almasio, Piero Luigi, et al.. (1990). Role of S-Adenosyl-L-Methionine in the Treatment of Intrahepatic Cholestasis. Drugs. 40(Supplement 3). 111–123. 41 indexed citations
17.
Cottone, Mario, et al.. (1989). Hospital Incidence of Crohn's Disease in the Province of Palermo :A Preliminary Report. Scandinavian Journal of Gastroenterology. 24(sup170). 27–28. 7 indexed citations
18.
Craxı̀, Antonio, M. Vinci, Piero Luigi Almasio, & L. Pagliaro. (1989). Hepatitis B vaccination of relatives of hepatitis B virus DNA positive carriers: An experience with plasma-derived vaccine. European Journal of Epidemiology. 5(1). 65–69. 2 indexed citations
19.
Craxı̀, Antonio, Giovanni Raimondo, Giuseppe Longo, et al.. (1984). Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.. Gut. 25(11). 1288–1290. 28 indexed citations
20.
Cottone, Mario, Elio Sciarrino, Alberto Maringhini, et al.. (1983). Ultrasound in the screening of patients with cirrhosis with large varices.. BMJ. 287(6391). 533.1–533. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026